Till Baernighausen, M.D.,Ph.D., Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anti-HIV Agents | 6 | 2023 | 4255 | 0.500 |
Why?
|
HIV Infections | 11 | 2023 | 16715 | 0.420 |
Why?
|
Anti-Retroviral Agents | 2 | 2011 | 1714 | 0.390 |
Why?
|
Haemophilus influenzae type b | 1 | 2010 | 16 | 0.390 |
Why?
|
Haemophilus Vaccines | 1 | 2010 | 69 | 0.380 |
Why?
|
Haemophilus Infections | 1 | 2010 | 95 | 0.380 |
Why?
|
Evaluation Studies as Topic | 1 | 2012 | 1681 | 0.350 |
Why?
|
Rural Health Services | 2 | 2010 | 379 | 0.330 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2012 | 1872 | 0.320 |
Why?
|
Burkina Faso | 6 | 2023 | 88 | 0.310 |
Why?
|
Health Services Accessibility | 4 | 2022 | 5135 | 0.310 |
Why?
|
Physician Incentive Plans | 1 | 2009 | 161 | 0.310 |
Why?
|
Health Personnel | 4 | 2022 | 3219 | 0.300 |
Why?
|
Medically Underserved Area | 1 | 2009 | 253 | 0.290 |
Why?
|
Program Evaluation | 2 | 2012 | 2488 | 0.270 |
Why?
|
Delivery of Health Care | 4 | 2023 | 5321 | 0.260 |
Why?
|
Financing, Personal | 1 | 2007 | 308 | 0.250 |
Why?
|
Health Benefit Plans, Employee | 1 | 2007 | 332 | 0.250 |
Why?
|
Africa South of the Sahara | 3 | 2012 | 724 | 0.230 |
Why?
|
Emigration and Immigration | 2 | 2021 | 402 | 0.220 |
Why?
|
Needs Assessment | 1 | 2008 | 1146 | 0.210 |
Why?
|
Population Surveillance | 1 | 2011 | 2616 | 0.190 |
Why?
|
Technology Assessment, Biomedical | 1 | 2023 | 306 | 0.190 |
Why?
|
Bacillus thuringiensis | 1 | 2019 | 13 | 0.180 |
Why?
|
Fellowships and Scholarships | 1 | 2008 | 1078 | 0.180 |
Why?
|
Medication Adherence | 1 | 2011 | 2063 | 0.180 |
Why?
|
Pest Control, Biological | 1 | 2019 | 20 | 0.180 |
Why?
|
Mental Health | 3 | 2022 | 3014 | 0.170 |
Why?
|
Intention | 1 | 2022 | 342 | 0.170 |
Why?
|
Infant Mortality | 1 | 2024 | 754 | 0.170 |
Why?
|
Mosquito Control | 1 | 2019 | 104 | 0.160 |
Why?
|
Vaccination | 1 | 2010 | 3279 | 0.160 |
Why?
|
Parturition | 1 | 2022 | 441 | 0.160 |
Why?
|
Transients and Migrants | 1 | 2021 | 155 | 0.160 |
Why?
|
Insecticides | 1 | 2019 | 195 | 0.150 |
Why?
|
Anopheles | 1 | 2019 | 197 | 0.150 |
Why?
|
History, 18th Century | 1 | 2017 | 213 | 0.140 |
Why?
|
Ethiopia | 3 | 2022 | 495 | 0.130 |
Why?
|
Social Stigma | 1 | 2021 | 701 | 0.130 |
Why?
|
Insurance, Health | 1 | 2007 | 2494 | 0.120 |
Why?
|
History, 19th Century | 1 | 2017 | 720 | 0.120 |
Why?
|
Nigeria | 3 | 2022 | 733 | 0.120 |
Why?
|
Tanzania | 3 | 2022 | 1346 | 0.100 |
Why?
|
Poverty | 1 | 2023 | 2660 | 0.100 |
Why?
|
Research Design | 2 | 2017 | 5986 | 0.100 |
Why?
|
Cost-Benefit Analysis | 3 | 2023 | 5390 | 0.100 |
Why?
|
Pandemics | 4 | 2023 | 8386 | 0.090 |
Why?
|
Public Health | 1 | 2024 | 2602 | 0.090 |
Why?
|
Tuberculosis | 2 | 2015 | 1912 | 0.090 |
Why?
|
Humans | 28 | 2024 | 744376 | 0.090 |
Why?
|
History, 20th Century | 1 | 2017 | 2740 | 0.090 |
Why?
|
Ambulatory Care Facilities | 1 | 2015 | 934 | 0.080 |
Why?
|
Models, Econometric | 1 | 2008 | 218 | 0.080 |
Why?
|
Telephone | 2 | 2021 | 617 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 3922 | 0.070 |
Why?
|
Costs and Cost Analysis | 1 | 2012 | 1680 | 0.070 |
Why?
|
Rural Health | 1 | 2007 | 305 | 0.070 |
Why?
|
Sentinel Surveillance | 1 | 2007 | 281 | 0.060 |
Why?
|
South Africa | 3 | 2022 | 1731 | 0.060 |
Why?
|
Family Planning Services | 1 | 2007 | 263 | 0.060 |
Why?
|
Angola | 1 | 2023 | 16 | 0.060 |
Why?
|
Liberia | 1 | 2024 | 167 | 0.060 |
Why?
|
Contraception | 1 | 2007 | 359 | 0.060 |
Why?
|
Lesotho | 1 | 2023 | 70 | 0.060 |
Why?
|
Monte Carlo Method | 1 | 2008 | 1254 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2009 | 804 | 0.060 |
Why?
|
Quality-Adjusted Life Years | 1 | 2008 | 1683 | 0.050 |
Why?
|
Child Mortality | 1 | 2024 | 198 | 0.050 |
Why?
|
England | 1 | 2023 | 522 | 0.050 |
Why?
|
Glomerular Filtration Rate | 1 | 2009 | 2166 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2010 | 941 | 0.050 |
Why?
|
Biomedical Research | 1 | 2017 | 3309 | 0.050 |
Why?
|
China | 1 | 2007 | 2245 | 0.050 |
Why?
|
Child | 6 | 2024 | 77708 | 0.050 |
Why?
|
Germany | 1 | 2023 | 862 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2008 | 2232 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2022 | 629 | 0.040 |
Why?
|
Poverty Areas | 1 | 2021 | 275 | 0.040 |
Why?
|
Sexual Partners | 1 | 2023 | 729 | 0.040 |
Why?
|
Female | 13 | 2024 | 380200 | 0.040 |
Why?
|
Bangladesh | 1 | 2021 | 687 | 0.040 |
Why?
|
Larva | 1 | 2019 | 519 | 0.040 |
Why?
|
AIDS Serodiagnosis | 2 | 2010 | 184 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25041 | 0.040 |
Why?
|
Child, Preschool | 3 | 2022 | 41005 | 0.040 |
Why?
|
Health Services | 1 | 2022 | 758 | 0.040 |
Why?
|
Patient Care Team | 1 | 2008 | 2531 | 0.040 |
Why?
|
Maternal Health Services | 1 | 2021 | 455 | 0.030 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2007 | 2026 | 0.030 |
Why?
|
Child Health Services | 1 | 2021 | 667 | 0.030 |
Why?
|
Health Care Costs | 1 | 2008 | 3209 | 0.030 |
Why?
|
Computer Simulation | 1 | 2008 | 6194 | 0.030 |
Why?
|
Educational Status | 1 | 2022 | 2540 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 2 | 2023 | 3020 | 0.030 |
Why?
|
Prevalence | 3 | 2023 | 15221 | 0.030 |
Why?
|
Alkynes | 1 | 2015 | 306 | 0.030 |
Why?
|
Adult | 7 | 2023 | 214056 | 0.030 |
Why?
|
Nevirapine | 1 | 2015 | 267 | 0.030 |
Why?
|
Lamivudine | 1 | 2015 | 342 | 0.030 |
Why?
|
Cyclopropanes | 1 | 2015 | 416 | 0.030 |
Why?
|
Benzoxazines | 1 | 2015 | 301 | 0.030 |
Why?
|
Primary Health Care | 1 | 2010 | 4557 | 0.030 |
Why?
|
Male | 8 | 2023 | 350118 | 0.030 |
Why?
|
Motivation | 1 | 2023 | 1971 | 0.030 |
Why?
|
Urban Population | 1 | 2021 | 2022 | 0.030 |
Why?
|
Zidovudine | 1 | 2015 | 620 | 0.030 |
Why?
|
Infant | 2 | 2015 | 35134 | 0.030 |
Why?
|
Pregnancy | 3 | 2022 | 29144 | 0.030 |
Why?
|
Qualitative Research | 1 | 2021 | 2682 | 0.030 |
Why?
|
Income | 1 | 2021 | 1913 | 0.030 |
Why?
|
Mothers | 1 | 2022 | 2165 | 0.020 |
Why?
|
Health Behavior | 1 | 2022 | 2635 | 0.020 |
Why?
|
Adolescent | 4 | 2023 | 85784 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7785 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2902 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3888 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 2560 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2012 | 63115 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 9957 | 0.020 |
Why?
|
Selection Bias | 1 | 2007 | 371 | 0.020 |
Why?
|
Diet | 1 | 2023 | 7937 | 0.020 |
Why?
|
Young Adult | 2 | 2021 | 56434 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5952 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 77459 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 25628 | 0.010 |
Why?
|
Risk Factors | 2 | 2023 | 72295 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10388 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2007 | 2715 | 0.010 |
Why?
|
Prenatal Care | 1 | 2007 | 1092 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 213388 | 0.010 |
Why?
|
Aged | 2 | 2021 | 163284 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15535 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 9849 | 0.010 |
Why?
|
Logistic Models | 1 | 2009 | 13409 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14723 | 0.010 |
Why?
|
Animals | 1 | 2019 | 168770 | 0.000 |
Why?
|
Prospective Studies | 1 | 2009 | 53291 | 0.000 |
Why?
|